Product
JS012
1 clinical trial
1 indication
Indication
Advanced or Metastatic Solid TumorsClinical trial
A Phase I Clinical Study Evaluating the Safety ,Tolerability, Pharmacokinetics of JS012 in Patients With Advanced or Metastatic Solid TumorsStatus: Terminated, Estimated PCD: 2022-09-19